CN114392319A - Traditional Chinese medicine composition for treating early stage of diabetes and application thereof - Google Patents
Traditional Chinese medicine composition for treating early stage of diabetes and application thereof Download PDFInfo
- Publication number
- CN114392319A CN114392319A CN202210079523.4A CN202210079523A CN114392319A CN 114392319 A CN114392319 A CN 114392319A CN 202210079523 A CN202210079523 A CN 202210079523A CN 114392319 A CN114392319 A CN 114392319A
- Authority
- CN
- China
- Prior art keywords
- parts
- diabetes
- traditional chinese
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 81
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 244000197580 Poria cocos Species 0.000 claims abstract description 26
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 241000132012 Atractylodes Species 0.000 claims abstract description 24
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 21
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 21
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 21
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 21
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 18
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 17
- 235000006533 astragalus Nutrition 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 241000308663 Eupatorium fortunei Species 0.000 claims abstract description 6
- 201000009104 prediabetes syndrome Diseases 0.000 claims description 22
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims description 17
- 208000001280 Prediabetic State Diseases 0.000 claims description 16
- 241000735527 Eupatorium Species 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 abstract description 51
- 230000000694 effects Effects 0.000 abstract description 18
- 206010067484 Adverse reaction Diseases 0.000 abstract description 5
- 230000006838 adverse reaction Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 description 20
- 210000004072 lung Anatomy 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 229960001031 glucose Drugs 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 239000002398 materia medica Substances 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 7
- 208000002705 Glucose Intolerance Diseases 0.000 description 6
- 206010056997 Impaired fasting glucose Diseases 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 229940107666 astragalus root Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000007410 oral glucose tolerance test Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 4
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 238000002791 soaking Methods 0.000 description 4
- 230000003393 splenic effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000282461 Canis lupus Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000218202 Coptis Species 0.000 description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 241000233855 Orchidaceae Species 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000019902 chronic diarrheal disease Diseases 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 244000248557 Ophiopogon japonicus Species 0.000 description 2
- 235000001188 Peltandra virginica Nutrition 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010065941 Central obesity Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000827125 Lupinus flavoculatus Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000031877 prophase Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating early diabetes and application thereof, wherein the traditional Chinese medicine composition is prepared from the following raw material medicines: 10-20 parts of coptis chinensis, 20-35 parts of astragalus membranaceus, 20-30 parts of Chinese yam, 12-30 parts of rhizoma atractylodis, 10-20 parts of eupatorium fortunei, 15-30 parts of fried bighead atractylodes rhizome, 15-30 parts of poria cocos and 10-30 parts of radix ophiopogonis. The traditional Chinese medicine composition is supported by the traditional Chinese medicine classic theory, has reasonable formula and proper compatibility, can tonify spleen and qi, clear heat and dry dampness, thereby treating the early stage of diabetes, and has the advantages of definite curative effect, obvious effect, no obvious adverse reaction and good safety.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating early stage diabetes and application thereof.
Background
Pre-diabetes is an important step in the transition from euglycemia to type 2 diabetes. Pre-diabetes refers to an abnormal state between the normal glycometabolism and diabetes, manifested by Impaired Glucose Regulation (IGR), including Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT), or both. In recent years, the incidence rate of the early stage of diabetes is rapidly increased, and large-scale cross-sectional investigation and research show that the prevalence rate of the early stage of diabetes of Chinese adults exceeds 50 percent and becomes an important reserve army for the type 2 diabetes. Blood glucose abnormality in the pre-diabetic stage is not only a risk factor of type 2 diabetes, but also closely related to cardiovascular diseases, metabolic syndrome, cognitive dysfunction and other diseases. However, the abnormal state of sugar metabolism in the prediabetes stage is a reversible process, so that the timely discovery and active intervention in the prediabetes stage is significant for delaying or blocking the onset of diabetes.
At present, the control method of the western medicine to the early stage of diabetes mainly comprises life style intervention, blood sugar reduction, Insulin Resistance (IR) improvement and the like, and the specificity is lacked. In recent years, Chinese medicines are also researched in the aspect of treating the early stage of diabetes, and Chinese scholars achieve certain achievements in various aspects such as prevention of the early stage of diabetes from developing into diabetes, alleviation and delay of complications and the like through years of clinical practice, for example, patent CN109223902A discloses a Chinese medicinal composition for intervening in the early stage of diabetes, which is prepared from 2-10 parts of raw hawthorn, 1-6 parts of medlar, 1-6 parts of cassia seed, 1-6 parts of wild chrysanthemum flower and 1-4 parts of dark plum; patent CN102836358A discloses a traditional Chinese medicine composition for treating pre-stage diabetes, which is prepared from 1-10 parts of bighead atractylodes rhizome, 1-10 parts of dried lily bulb, 2-10 parts of dried rehmannia root, 2-10 parts of astragalus root, 1-5 parts of coptis root, 2-6 parts of coix seed, 2-6 parts of angelica regale and 2-6 parts of sophora flower bud. Compared with western medicine, the traditional Chinese medicine has the advantages of definite curative effect, less adverse reaction and the like.
Although the above patent applications describe that the traditional Chinese medicine prescription has a certain curative effect, in view of the large market demand of the medicines for treating the early stage of diabetes and the different constitutions of each patient, the existing traditional Chinese medicine prescription has the problems of uncertain curative effect and insignificant effect, so that the development of a traditional Chinese medicine preparation with definite curative effect, simple and convenient administration, safety and no toxic or side effect is urgently needed, and more medication options are provided for clinicians and patients.
Disclosure of Invention
In order to solve the defects of the prior art, the invention aims to provide the traditional Chinese medicine composition for treating the early stage of diabetes, which has a reasonable formula and a remarkable effect.
The above object of the present invention can be achieved by the following technical solutions:
a traditional Chinese medicine composition for treating pre-diabetes is prepared from the following raw material medicines in parts by weight: 10-20 parts of coptis chinensis, 20-35 parts of astragalus membranaceus, 20-30 parts of Chinese yam, 12-30 parts of rhizoma atractylodis, 10-20 parts of eupatorium fortunei, 15-30 parts of fried bighead atractylodes rhizome, 15-30 parts of poria cocos and 10-30 parts of radix ophiopogonis.
Preferably, the traditional Chinese medicine composition for treating the pre-stage diabetes is prepared from the following raw material medicines in parts by weight: 10-15 parts of coptis chinensis, 20-25 parts of astragalus membranaceus, 20-25 parts of Chinese yam, 12-20 parts of rhizoma atractylodis, 10-15 parts of eupatorium fortunei, 15-20 parts of fried bighead atractylodes rhizome, 15-20 parts of poria cocos and 10-20 parts of radix ophiopogonis.
Preferably, the traditional Chinese medicine composition for treating the pre-stage diabetes is prepared from the following raw material medicines in parts by weight: 10 parts of coptis chinensis, 20 parts of astragalus membranaceus, 20 parts of Chinese yam, 12 parts of rhizoma atractylodis, 10 parts of fortune eupatorium herb, 15 parts of fried bighead atractylodes rhizome, 15 parts of poria cocos and 10 parts of radix ophiopogonis.
Preferably, the traditional Chinese medicine composition for treating the pre-diabetes comprises a medically acceptable drug carrier.
The invention also aims to disclose the application of the traditional Chinese medicine composition in preparing a medicine for treating pre-diabetes.
Preferably, the dosage form of the medicine is granules, oral liquid, tablets, capsules, powder, pills or paste.
The invention has the following beneficial effects:
the traditional Chinese medicine composition is supported by the traditional Chinese medicine classic theory, has reasonable formula and proper compatibility, can tonify spleen and qi, clear heat and dry dampness, thereby treating the early stage of diabetes, and has the advantages of definite curative effect, obvious effect, no obvious adverse reaction and good safety.
The traditional Chinese medicine composition can be used for preparing medicines for treating the early stage of diabetes, can be selected from various dosage forms, and has the advantages of convenient treatment, long drug effect, portability of the medicines, stable curative effect, strong medicine economy and the like while ensuring the curative effect.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments, and it should be understood that the described embodiments are some, but not all, embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention relates to a traditional Chinese medicine composition for treating early diabetes, which is prepared from the following raw material medicines: coptis root, astragalus root, Chinese yam, rhizoma atractylodis, fortune eupatorium herb, stir-fried bighead atractylodes rhizome, tuckahoe and dwarf lilyturf tuber.
Traditional Chinese medicine has no name of pre-diabetes, and can be classified as 'splenic fever' according to the symptoms of patients. The name of "Piyi" is first reported in Huangdi's classic on medicine. The literature of Su Wen & Qi Bin Lun (Su Wen & Qi disease): "is the disease name for those with a sweet taste? What can it be? The Qibo is given as follows: the five qi overflow is also named as splenic fever … …, and the person must eat sweet and beautiful food and have much fat, the fat person is hot, and the sweet person is full of qi, so the qi overflow turns into diabetes, which indicates that the important cause of splenic fever is overeating and fatty food, and the full of internal heat is generated and accumulated in the spleen, and the person can not intervene in time and possibly progress to diabetes. In addition, the "Huangdi's classic on medicine" also proposes the treatment principle of "splenic fever": treating the orchid and removing the old qi, namely, adopting the aromatic spleen-enlivening herbs to remove the turbid and remove the dampness. Later doctors mostly give play to theoretical understanding of "spleen fever" on the basis of "Huangdi's Nei Jing", but think that the disease is located in the spleen, and the cause of the disease is not innate endowment, overfeeding sweet and delicious, ease and move little, emotional disorder and the like. The pathogenesis is mainly qi deficiency, and qi stagnation, dryness-heat and phlegm accumulation are the symptoms. Therefore, the prescription of the invention aims at invigorating spleen and replenishing qi, clearing heat and drying dampness, thereby treating the clinical symptoms of the early stage of diabetes. The invention has the following meanings:
monarch drug: astragalus root, Chinese yam. Astragalus root: sweet in flavor, it enters spleen and lung meridians. Tonify qi, strengthen superficies, expel toxin, expel pus, induce diuresis, and promote granulation. Shen nong Ben Cao Jing (Shen nong's herbal), radix astragali is sweet in flavor and slightly warm in nature. Mainly carbuncle, cellulitis, long-term septicemia, pus discharge and pain relief, leprosy, five hemorrhoids, mouse fistula, deficiency tonifying and various diseases of children. "Chinese yam: sweet and neutral in nature, they enter spleen, lung and kidney meridians. Tonify spleen and stomach, promote the production of body fluid and nourish lung, tonify kidney and astringe essence. The book materia Medica is as follows: chinese yam can invigorate spleen, tonify deficiency, nourish essence and strengthen kidney, and treat consumptive disease and seven injuries. "(the book of materia Medica): the yam can tonify kidney and replenish essence, and the essence can strengthen yin, improve eyesight and improve hearing. The two are monarch drugs, which achieve the effects of strengthening the spleen, replenishing qi, assisting the spleen to dissipate essence.
Ministerial drugs: coptidis rhizoma, and radix Ophiopogonis. Coptis chinensis: bitter and cold in flavor, entering heart, spleen, stomach, liver, gallbladder and large intestine meridians. Clear heat and dry dampness, purge fire and remove toxicity. Compendium of materia Medica: purging liver fire, removing heart orifice and aversion to blood, stopping palpitation. "miscellaneous records of famous physicians": it is slightly cold and non-toxic. The traditional Chinese medicine composition is mainly used for treating cold and heat in five kinds of zang, chronic diarrhea and purulent blood, relieving thirst and convulsion, removing water, benefiting bones, regulating stomach, thickening intestines, benefiting gallbladder and treating aphtha. ' radix ophiopogonis: sweet, slightly bitter and slightly cold. It enters heart, lung and stomach meridians. Nourish yin, promote the production of body fluid, moisten lung and arrest cough. The miscellaneous records of famous physicians: "heaviness of the body and eyes yellow, fullness in the lower heart, consumptive disease, fever in the chest, dry and thirsty, vomiting stopping, atrophy, coldness, yin strengthening and essence benefiting, grain elimination and middle regulation, mental tranquilization, lung qi fixing, five internal organs calming, body building, skin color beautifying, son of the book" materia medica "emission-picking: "stop feverish sensation in the chest, thirst, heaviness of the body, yellow eyes, chills and fever, fatigue, stop vomiting, stimulate the appetite, and expel phlegm". The two medicines are used as ministerial medicines to achieve the effects of clearing heat, drying dampness, nourishing yin and promoting the production of body fluid.
Adjuvant drugs: atractylodis rhizoma, Poria, rhizoma Atractylodis, and herba Eupatorii. White atractylodes rhizome: bitter, sweet and warm, entering spleen and stomach meridians. Invigorate spleen, replenish qi, dry dampness, induce diuresis, stop sweating, prevent abortion. The herbal medicine Tongxian: herbs that tonify spleen and stomach do not go beyond the right. It is also indicated for food failure, food stagnation and distension and fullness because it can strengthen the body's movement with vigorous soil. When the body is too strong, it can clear dampness, so it is also used for phlegm-fluid retention, swelling and damp arthralgia. The book Ben Cao Hui Yan (treatise on materia Medica): bighead atractylodes rhizome, rhizoma Atractylodis Macrocephalae, is also the key herb for strengthening the spleen and stomach, dissipating dampness and removing arthralgia, promoting digestion and removing stuffiness. "the materia Medica: bighead atractylodes rhizome, rhizoma Atractylodis Macrocephalae, bitter and sweet in taste, can dry dampness and strengthen spleen, and can relieve spleen and promote fluid production. Moreover, it is the warmest in nature, so it can be used as the first herb for spleen qi tonify to promote digestion and to eliminate food stagnation when taken. "Poria cocos: sweet and bland, entering heart, lung, spleen and kidney meridians. Induce diuresis and drain dampness, invigorate spleen and calm heart. Compendium of materia Medica: poria cocos, Poria cocos, Poria, belongs to yang, and belongs to the yang, and also refers to the property of nature, nourishing water, promoting urination, and inducing diuresis; dongyuan means that it is the yin in yang and descending, so it is also called the action. "(materia Medica of materia Medica): poria cocos, Poria cocos wolf and Poria cocos wolf have the action of moving water, and can tonify heart and spleen, and do not reach the limit. "(materia Medica): the Chinese medicinal composition has the effects of inducing resuscitation and removing dampness, and inducing resuscitation and restoring heart and intelligence, and promoting the production of body fluid; removing dampness can expel water and dry spleen, strengthen middle-jiao and invigorate stomach; to treat epilepsy due to fright and thick intestine, it is indicated for phlegm and helps to descend. Because its taste is slightly sweet, it is said to tonify yang. But with less benefit and more profit. "rhizoma atractylodis: pungent, bitter and warm. It enters spleen, stomach and liver meridians. Dry dampness and invigorate spleen, dispel wind and cold, improve vision. Compendium of materia Medica: "Dafengbi", weak muscles and bones, dispelling wind, removing dampness and resolving stagnation ". The juice is used for brewing wine to treat all rheumatic arthralgia and myalgia. ". The herbal supplement: dryness in the stomach and strengthening the spleen. Sweating and dehumidifying. It can ascend yang qi in stomach. Stopping vomiting and diarrhea. Expelling phlegm. "Eupatorium: pungent flavor and mild property. Spleen, stomach and lung meridians. Fragrant, resolving dampness, activating spleen, stimulating appetite, relieving exterior syndrome and relieving summer-heat. Su Wen & Qi Bing Lun: body fluids are in the spleen, so it is also responsible for dry mouth and body mass. .., its qi overflows and turns into diabetes, so it is treated by orchid and removes old qi. "(Ben Cao Jing Shu): the lung governs qi, lung qi stagnation leads to upper orifice obstruction but lower orifice obstruction, the stomach mainly receives water and food, stomach qi stagnation leads to water not becoming phlegm nodule due to time-dependent change, the orchid pungent can dissipate stagnation, the fragrance can remove dirty and bad, the traditional Chinese medicines for treating various diseases are self-treatment, and most of the traditional Chinese medicines have the functions of appetizing, removing bad breath, removing phlegm and dispersing stagnation. The four medicines are used as adjuvant medicines together to achieve the effects of strengthening spleen, tonifying qi, eliminating dampness and promoting diuresis.
The whole formula is combined to play the effects of tonifying spleen and qi, clearing heat and drying dampness.
The traditional Chinese medicine composition comprises the following raw materials in parts by weight and has the pharmacological effects:
10-20 parts of coptis chinensis, 20-35 parts of astragalus membranaceus, 20-30 parts of Chinese yam, 12-30 parts of rhizoma atractylodis, 10-20 parts of eupatorium fortunei, 15-30 parts of fried bighead atractylodes rhizome, 15-30 parts of poria cocos and 10-30 parts of radix ophiopogonis.
Coptis chinensis: bitter and cold in flavor, entering heart, spleen, stomach, liver, gallbladder and large intestine meridians. Clear heat and dry dampness, purge fire and remove toxicity. Dampness-heat fullness, vomiting, acid regurgitation, dysentery, jaundice, high fever, coma, hyperactivity of heart-fire, vexation, insomnia, palpitation, hematemesis, epistaxis, conjunctival congestion, toothache, diabetes, carbuncle, swelling and sore; it can be used for treating eczema, and purulence in ear canal. Typical but non-limiting contents of coptis are: 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts and 20 parts.
Astragalus root: sweet and warm. It enters spleen and lung meridians. Tonify qi, strengthen superficies, expel toxin, expel pus, induce diuresis, and promote granulation. Can be used for treating deficiency of vital energy, asthenia, anorexia, loose stool, collapse of middle-warmer energy, chronic diarrhea, rectocele, hematochezia, spontaneous perspiration, qi deficiency, edema, internal heat, diabetes, blood deficiency, hemiplegia, arthralgia, numbness, carbuncle, cellulitis, and intractable ulcer. Typical but non-limiting contents of astragalus membranaceus are: 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts, 30 parts, 31 parts, 32 parts, 33 parts, 34 parts and 35 parts.
Chinese yam: sweet and neutral. It enters spleen, lung and kidney meridians. Tonify spleen and stomach, promote the production of body fluid and nourish lung, tonify kidney and astringe essence. Can be used for treating spleen deficiency, anorexia, chronic diarrhea, lung deficiency, cough, asthma, spermatorrhea, leukorrhagia, frequent micturition, asthenic fever, and diabetes. Typical but non-limiting contents of yam are: 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts and 30 parts.
Rhizoma atractylodis: pungent, bitter and warm. It enters spleen, stomach and liver meridians. Dry dampness and invigorate spleen, dispel wind and cold, improve vision. Can be used for treating damp obstruction of middle warmer, abdominal distention, diarrhea, edema, tinea pedis, atrophic debility cramped, rheumatalgia, wind-cold type common cold, night blindness, dim eyesight, and astringent taste. Typical but non-limiting contents of atractylodes rhizome are: 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts and 30 parts.
Herba Eupatorii: pungent flavor and mild property. Spleen, stomach and lung meridians. Fragrant, resolving dampness, activating spleen, stimulating appetite, relieving exterior syndrome and relieving summer-heat. Can be used for treating damp stagnation, abdominal distention, emesis, halitosis, sialism, summer-heat dampness syndrome, fever, listlessness, and chest distress. Typical but non-limiting amounts of eupatorium are: 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts and 20 parts.
Frying the bighead atractylodes rhizome: bitter, sweet and warm. It enters spleen and stomach meridians. Invigorate spleen, replenish qi, dry dampness, induce diuresis, stop sweating, prevent abortion. Can be used for treating spleen deficiency, anorexia, abdominal distention, diarrhea, phlegm retention, dizziness, palpitation, edema, spontaneous perspiration, and threatened abortion. Typical but non-limiting amounts of roasted white atractylodes rhizome are: 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts and 30 parts.
Tuckahoe, poria cocos: sweet and bland, entering heart, lung, spleen and kidney meridians. Can be used for treating edema, oliguria, phlegm and fluid retention, dizziness, palpitation, spleen deficiency, anorexia, loose stool, diarrhea, uneasiness, palpitation, and insomnia. Typical but non-limiting contents of poria cocos wolf are: 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts and 30 parts.
Radix ophiopogonis: sweet, slightly bitter and cold, entering heart, lung and stomach meridians. Nourish yin, promote the production of body fluid, moisten lung and arrest cough. Can be used for treating thirst, short breath, consumptive lung disease, cough due to dry lung, asthenia, and asthenic fever. Typical but non-limiting amounts of ophiopogon root are: 10 parts, 11 parts, 12 parts, 13 parts, 14 parts, 15 parts, 16 parts, 17 parts, 18 parts, 19 parts, 20 parts, 21 parts, 22 parts, 23 parts, 24 parts, 25 parts, 26 parts, 27 parts, 28 parts, 29 parts and 30 parts.
The other embodiment of the invention is a medicament for treating the pre-stage diabetes, which is prepared by processing the traditional Chinese medicine composition for treating the pre-stage diabetes and pharmaceutically acceptable auxiliary materials. The dosage form of the medicine is any one of granules, oral liquid, tablets, capsules, powder, pills and paste.
The technical solution of the present invention will be further described with reference to specific examples.
Example 1
A traditional Chinese medicine composition for treating pre-diabetes comprises the following raw material medicines by weight: 10 parts of coptis chinensis, 20 parts of astragalus membranaceus, 20 parts of Chinese yam, 12 parts of rhizoma atractylodis, 10 parts of fortune eupatorium herb, 15 parts of fried bighead atractylodes rhizome, 15 parts of poria cocos and 10 parts of radix ophiopogonis.
The preparation and administration method comprises the following steps: soaking the medicinal materials in clear water for half an hour, boiling with strong fire, decocting with slow fire for 30 min, decocting the first part, adding water, decocting for 20 min, decocting the second part, mixing the two decoctions, and taking the mixture twice in the morning and evening.
Example 2
A traditional Chinese medicine composition for treating pre-diabetes comprises the following raw material medicines by weight: 10 parts of coptis chinensis, 30 parts of astragalus membranaceus, 30 parts of Chinese yam, 15 parts of rhizoma atractylodis, 15 parts of fortune eupatorium herb, 15 parts of fried bighead atractylodes rhizome, 10 parts of poria cocos and 10 parts of radix ophiopogonis.
The preparation method comprises the following steps: weighing the above materials according to the dosage, adding water to immerse the materials, soaking for 3 hr, heating to boil, decocting for 0.5 hr, and collecting decoction. Decocting the residue by the method for 2-3 times, and mixing decoctions. Filtering, concentrating by evaporation (1:1), cooling, adding 1.5 times of ethanol, mixing, standing overnight, collecting supernatant, washing precipitate with a little 50% ethanol, mixing the washing solution with the filtrate, recovering ethanol under reduced pressure, concentrating, cooling, standing, filtering, vacuum concentrating at low temperature to obtain soft extract with specific gravity of 1.33, spray drying, sieving with 300 mesh sieve, adding appropriate amount of adjuvants, and making into granule.
Example 3
A traditional Chinese medicine composition for treating pre-diabetes comprises the following raw material medicines by weight: 10 parts of coptis chinensis, 25 parts of astragalus membranaceus, 25 parts of Chinese yam, 12 parts of rhizoma atractylodis, 10 parts of fortune eupatorium herb, 15 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos and 15 parts of radix ophiopogonis.
The preparation method comprises the following steps: weighing the above medicinal materials according to the dosage, pulverizing three fifths of the medicinal materials, sieving with a 50 mesh sieve, adding water to immerse the medicinal materials, soaking for 3 hr, heating to boil, decocting for 0.5 hr, and collecting decoction. Decocting the residue by the method for 2-3 times, and mixing decoctions. Filtering, concentrating by evaporation (1:1), cooling, adding 1.5 times of ethanol, mixing, standing overnight, collecting supernatant, washing precipitate with a little 50% ethanol, mixing the washing solution with the filtrate, recovering ethanol under reduced pressure, concentrating, cooling, standing, filtering, vacuum concentrating at low temperature to obtain soft extract with specific gravity of 1.33, spray drying, grinding, sieving with 300 mesh sieve to obtain extract powder, and making into capsule.
Example 4
A traditional Chinese medicine composition for treating pre-diabetes comprises the following raw material medicines by weight: 15 parts of coptis chinensis, 30 parts of astragalus membranaceus, 30 parts of Chinese yam, 12 parts of rhizoma atractylodis, 20 parts of fortune eupatorium herb, 30 parts of fried bighead atractylodes rhizome, 30 parts of poria cocos and 10 parts of radix ophiopogonis.
The preparation method comprises the following steps: weighing the raw materials according to the weight, drying, micronizing to obtain particles above 800 meshes, adding appropriate amount of dextrin, stirring, and making into tablet.
Example 5
A traditional Chinese medicine composition for treating pre-diabetes comprises the following raw material medicines by weight: 15 parts of coptis chinensis, 30 parts of astragalus membranaceus, 30 parts of Chinese yam, 20 parts of rhizoma atractylodis, 20 parts of fortune eupatorium herb, 25 parts of fried bighead atractylodes rhizome, 25 parts of poria cocos and 25 parts of radix ophiopogonis.
The preparation method comprises the following steps: weighing the above materials according to the dosage, adding water to immerse the materials, soaking for 3 hr, heating to boil, decocting for 0.5 hr, and collecting decoction. Decocting the residue by the method for 2-3 times, and mixing decoctions. Filtering, concentrating by evaporation (1:1), cooling, adding 1.5 times of ethanol, mixing, standing overnight, collecting supernatant, washing precipitate with a small amount of 50% ethanol, mixing the washing solution with the filtrate, recovering ethanol under reduced pressure, concentrating, cooling, standing, filtering, and vacuum concentrating at low temperature to obtain fluid extract with specific gravity of 1.20-1.35; drying the second residue, pulverizing into fine powder as additive, mixing the fine powder with the fluid extract with a specific gravity of 1.20-1.35, stirring to obtain mixture, and spray drying with water vapor gas or nitrogen gas as atomizing gas to obtain medicinal powder granule.
Clinical trial
1. Study object
60 cases of diabetes mellitus early-stage patients diagnosed in the endocrinology of traditional Chinese medicine of the first hospital in Ningbo city are selected, and the patients are divided into 30 cases of traditional Chinese medicines and 30 cases of western medicines according to whether a heat-clearing and qi-tonifying prescription is adopted for treatment. The mean ages of the two groups of patients were (42.43 + -4.93), (42.83 + -4.90), respectively, and the difference was not statistically significant (P > 0.05). The two groups of patients found that the blood sugar abnormal time, BMI and waist-hip ratio were not statistically different (P is more than 0.05), and were comparable.
2. Execution standard and method
(1) Diagnostic criteria
Impaired Fasting Glucose (IFG): fasting venous plasma glucose (FBG) is more than or equal to 6.1mmol/L and less than 7.0 mmol/L; and 75g post Oral Glucose Tolerance Test (OGTT) plasma glucose < 7.8 mmol/L.
Impaired Glucose Tolerance (IGT): fasting venous plasma glucose < 7.0mmol/L (126mg/d 1); and plasma glucose (2hPG) 2 hours after 75g oral glucose tolerance test is more than or equal to 7.8mmoL/L and less than 11.1 mmoL/L.
The standards of impaired fasting glucose, impaired glucose tolerance or impaired fasting glucose combined with impaired glucose tolerance are all diabetes mellitus prophase.
(2) The treatment method comprises the following steps:
the traditional Chinese medicine comprises: 10 parts of coptis chinensis, 20 parts of astragalus membranaceus, 20 parts of Chinese yam, 12 parts of rhizoma atractylodis, 10 parts of fortune eupatorium herb, 15 parts of fried bighead atractylodes rhizome, 15 parts of poria cocos and 10 parts of radix ophiopogonis. The decoction is taken by water, one dose is taken every day, and the decoction is taken in the morning and the evening. Each menstrual cycle is 1 course, and the treatment course is 3.
Western medicine group: metformin, 250mg once, 2 times a day, is taken after meals.
(3) Observation indicator and method
1) General conditions
Demographic data: age, sex;
② the past medical history, family history and treatment history: the course of the diabetes, family history of diabetes, other diseases and their corresponding treatment history;
the living habits: history of smoking and drinking;
fourthly, physical examination: BMI (BMI <24 normal, 24-28 overweight, >28 obesity), waist circumference (female waist circumference less than or equal to 80, male waist circumference less than or equal to 90 normal, female waist circumference >80, male >90 central obesity).
2) Index of therapeutic effect
The sugar tolerance recurrence rate of the traditional Chinese medicine group and the western medicine group after 12 weeks. At the 12-week follow-up visit, an Oral Glucose Tolerance Test (OGTT) was performed at the last follow-up visit, and the glucose tolerance state of the patient was judged from the results of the test.
3) Glycolipid metabolism related indices
(ii) Fasting Plasma Glucose (FPG);
(ii) Post-prandial glucose (PPG);
③ glycated hemoglobin (HemoglobinA a1C, HbA1C) (0, 12 weeks follow-up);
fasting insulin (at 0, 12 week follow-up);
blood lipid (total Cholesterol (TC), Triglyceride (TG), low density lipoprotein Cholesterol (lowdensity lipoprotein-Cholesterol, LDL-C), high density lipoprotein Cholesterol (HDL-C)) (at follow-up for 0, 12 weeks);
sixthly, insulin resistance index (HOMA-IR).
The patients had fasting plasma glucose for more than eight hours (glucose oxidase method), HbA1C (high pressure liquid chromatography) and lipid metabolism related index (enzyme method), and the subjects had taken 75g of anhydrous glucose powder and 2 hours thereafter, postprandial plasma glucose was measured (glucose oxidase method).
(4) Statistical method
Statistical description and analysis data processing was performed using SPSS25.0 statistical software. The measured data conforms to the normal distributionThe rate, composition ratio, etc. describe the patient's general condition, BMI, waist circumference, hip circumference, etc., and M (P) is used in a non-normal distribution25,P75) Representing that the measurement data conforms to normal distribution and adopts t test, and does not conform to normal distribution and adopts rank sum test; counting data are described by frequency and percentage, and binary data are compared between groups by adopting a chi 2 test or a Fisher test with exact probability. P<A difference of 0.05 is statistically significant.
3. Results of the study
(1) Observation and comparison of monitoring index
As shown in Table 1, FPG, 2hPG, HbA1c and HOMA-IR indexes before and after administration of the Chinese medicinal composition and the western medicinal composition in each group have statistical significance, fasting blood sugar, postprandial blood sugar and glycosylated hemoglobin are all reduced, and insulin resistance is reduced. The differences of TC and LDL before and after the traditional Chinese medicine group is used have statistical significance (P is less than 0.05), and the differences of TG and HDL have no statistical significance (P is more than 0.05). The differences of LDL before and after the western medicine is taken have statistical significance (P is less than 0.05), and the differences of TC, TG and HDL have no statistical significance (P is more than 0.05).
(2) Observation and comparison of two groups of post-medication monitoring indexes
After the traditional Chinese medicine group is used, the improvement degrees of FBG, 2hPG, HbA1c, HOMA-IR, TC and LDL are more obvious than those of the western medicine group, and the difference has statistical significance (P is less than 0.05). The improvement of TG and HDL is not obvious.
(3) Safety evaluation index
No obvious adverse reaction is seen in the two groups.
The research result shows that: the traditional Chinese medicine compound can reduce the blood sugar condition of a patient, improve the pancreatic islet function and clinical symptoms of the patient, has no obvious adverse reaction, and has better safety.
Typical case
Case 1: luo Shi, male, 62 years old, married. The main complaints are: blood glucose was found to be higher for 1 year. The current medical history: the physical examination in 2020 shows that the blood sugar is high, FBG: 6.4mmol/L, 2 hPG: 7.6mmol/L, which is not regarded and treated. FBG was found by physical examination in 2021: 6.8mmol/L, 2 hPG: 10.2mmol/L, the patient will be diagnosed in 2021, 9 months and 1 day, and the symptoms are shown as follows: generally, the food is fat in shape, does not have obvious symptoms of thirst, desire for drinking, weight loss, dryness and astringency of eyes, soreness and weakness of waist and knees and the like, and can be taken orally, calm and loose stool. Pale-red tongue with thin, white coating and soft pulse. The syndrome belongs to the syndrome of spleen deficiency with excessive dampness, and the main therapeutic principle is to invigorate spleen, replenish qi and dry dampness. The method comprises the following steps: 10g of coptis chinensis, 20g of astragalus membranaceus, 20g of Chinese yam, 12g of rhizoma atractylodis, 10g of fortune eupatorium herb, 15g of fried bighead atractylodes rhizome, 15g of poria cocos and 10g of radix ophiopogonis, and the decoction is decocted with water to be taken, and one dose is taken in the morning and evening. Order patients to adjust life style, enhance exercise and make discomfort for follow-up diagnosis. After 3 months of treatment, blood was rechecked, FBG: 5.4mmol/L, 2 hPG: 5.9mmol/L, HbA1 c: 5.8 percent.
Case 2: chen, woman, age 35, married. The main complaints are: blood glucose was found to be higher for 1 year. The current medical history: FBG was found in unit physical examination 1 year ago: 6.3mmol/l, which is not regarded and treated. The patients feel dry mouth and thirst before and after 1 month, and visit the clinic, go to OGTT and FBG: 6.9mmol/L, 2 hPG: 9.8mmol/l, HbA1 c: 6.1 percent. The following symptoms are shown: swollen shape, dry mouth, thirst, impatience of spleen qi, no weight loss, no soreness and weakness of waist and knees, slight appetite, late sleep, dry and thin stool, reddened tongue with white fur, thick pulse string and thready pulse. The syndrome belongs to the syndrome of liver depression and spleen deficiency, and the retention of damp-heat in the interior is the main therapeutic principle of soothing the liver, strengthening the spleen, clearing heat and drying dampness. The method comprises the following steps: 10g of coptis chinensis, 20g of astragalus membranaceus, 20g of Chinese yam, 12g of rhizoma atractylodis, 10g of fortune eupatorium herb, 15g of fried bighead atractylodes rhizome, 15g of poria cocos and 10g of radix ophiopogonis, and the decoction is decocted with water to be taken, and one dose is taken in the morning and evening. Order the patient to adjust the life style and make a diagnosis at any time. After 6 months of treatment, OGTT, FBG: 4.9mmol/L, 2 hPG: 6.5mmol/l, HbA1 c: 5.3 percent.
Although the present disclosure has been described above, the scope of the present disclosure is not limited thereto. Those skilled in the art can make various changes and modifications without departing from the spirit and scope of the present disclosure, and such changes and modifications will fall within the scope of the present invention.
Claims (6)
1. The traditional Chinese medicine composition for treating the early stage of diabetes is characterized by being prepared from the following raw material medicines in parts by weight: 10-20 parts of coptis chinensis, 20-35 parts of astragalus membranaceus, 20-30 parts of Chinese yam, 12-30 parts of rhizoma atractylodis, 10-20 parts of eupatorium fortunei, 15-30 parts of fried bighead atractylodes rhizome, 15-30 parts of poria cocos and 10-30 parts of radix ophiopogonis.
2. The traditional Chinese medicine composition for treating pre-diabetes according to claim 1, which is prepared from the following raw material medicines in parts by weight: 10-15 parts of coptis chinensis, 20-25 parts of astragalus membranaceus, 20-25 parts of Chinese yam, 12-20 parts of rhizoma atractylodis, 10-15 parts of eupatorium fortunei, 15-20 parts of fried bighead atractylodes rhizome, 15-20 parts of poria cocos and 10-20 parts of radix ophiopogonis.
3. The traditional Chinese medicine composition for treating pre-diabetes according to claim 1, which is prepared from the following raw material medicines in parts by weight: 10 parts of coptis chinensis, 20 parts of astragalus membranaceus, 20 parts of Chinese yam, 12 parts of rhizoma atractylodis, 10 parts of fortune eupatorium herb, 15 parts of fried bighead atractylodes rhizome, 15 parts of poria cocos and 10 parts of radix ophiopogonis.
4. The Chinese medicinal composition for treating pre-diabetes according to claim 1, comprising a pharmaceutically acceptable drug carrier.
5. The use of the Chinese medicinal composition according to any one of claims 1 to 4 in the preparation of a medicament for the treatment of pre-stage diabetes.
6. The use of claim 5, wherein the medicament is in the form of granules, oral liquid, tablets, capsules, powders, pills or creams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210079523.4A CN114392319A (en) | 2022-01-24 | 2022-01-24 | Traditional Chinese medicine composition for treating early stage of diabetes and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210079523.4A CN114392319A (en) | 2022-01-24 | 2022-01-24 | Traditional Chinese medicine composition for treating early stage of diabetes and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114392319A true CN114392319A (en) | 2022-04-26 |
Family
ID=81233118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210079523.4A Pending CN114392319A (en) | 2022-01-24 | 2022-01-24 | Traditional Chinese medicine composition for treating early stage of diabetes and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114392319A (en) |
-
2022
- 2022-01-24 CN CN202210079523.4A patent/CN114392319A/en active Pending
Non-Patent Citations (1)
Title |
---|
付惠萍等: "益气汤治疗气阴两虚2型糖尿病132例总结", 《中医药导报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102028900B (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
CN100435831C (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
CN105920514A (en) | Traditional Chinese medicinal composition for treating metabolic syndrome | |
CN102205107A (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN105031517A (en) | Dendrobium officinale healthcare tea capable of reducing blood fat, blood sugar, and blood pressure and preparation method thereof | |
CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
CN101607051A (en) | A kind of Chinese medicine Weight reducing compound and preparation method thereof | |
CN102526345B (en) | Chinese medicinal composition for treating hypertension | |
CN102872423B (en) | Traditional Chinese medicine compound for treating glycuresis and preparation method thereof | |
CN106822583A (en) | A kind of regulation blood pressure, blood fat, Chinese medicine composition of blood sugar and preparation method thereof | |
CN106511634A (en) | Traditional Chinese medicine composition for treating uarthritis and preparation method thereof | |
CN101757408A (en) | Medicament for treating lupus erythematosus and preparation method thereof | |
CN104042981A (en) | Medicament for treating postnatal constipation and preparation method thereof | |
CN101116686A (en) | Medicine for treating fatness and its complication | |
CN103393938B (en) | Traditional Chinese medicine composition for reducing blood sugar | |
CN103007159A (en) | Chinese medicinal preparation for correcting pancreas islet function | |
CN114392319A (en) | Traditional Chinese medicine composition for treating early stage of diabetes and application thereof | |
CN105194355A (en) | Traditional Chinese medicine preparation for treating primary hypertension | |
CN106729304B (en) | A kind of Chinese medicine for mitigating fasting or side reaction of dieting and preparation method thereof | |
CN110179966A (en) | The preparation method and applications of traditional Chinese medicine composition for relieving asthenopia | |
CN114712466B (en) | Medicine with weight-reducing and beautifying effects and preparation method thereof | |
CN103223107A (en) | Traditional Chinese medicine used for adjusting blood fat and blood pressure, and preparation technology thereof | |
CN108478739A (en) | A kind of health products and preparation method thereof adjusting equilibrium between yin and yang | |
CN106344808A (en) | Compound dendrobium officinale health care product capable of assisting in reducing blood sugar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220426 |
|
RJ01 | Rejection of invention patent application after publication |